Clinical Benefit of Insulin Glargine 300 U/mL Among Type 2 Diabetes Mellitus Patients Previously Uncontrolled On Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multi-Center, Real World Study
mediaposted on 2021-05-18, 16:17 authored by Milena VELOJIC-GOLUBOVIC, Vojislav CIRIC, Marija DIMITRIJEVIC, Tijana KOVIC, Milica MITIC, Biljana OLUJIC, Natasa PEVAC, Sasa RADENKOVIC, Danijela RADOJKOVIC, Selena VUKADINOVIC, Djordje S. POPOVIC
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.